An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data

An observational study «FOLLITROPIN» comparing the efficacy of follitropin alpha biosimilar: the real-world data

Introduction. The efficacy and safety of biosimilar follitropin alpha have been demonstrated in randomized blinded prospective clinical trials of phases I and III. Unfortunately, there is a gap between the clinical trials and real clinical practice data. The real-world patient data helps to create a...

Full description

Bibliographic Details
Main Authors: D. P. Kamilova, M. M. Ovchinnikova, E. Sh. Ablyaeva, M. M. Leviashvili, N. S. Stuleva, E. V. Broitman, M. A. Ganikhina, E. N. Mayasina, L. F. Iskhakova, K. Yu. Boyarskiy, E. N. Ovsyannikova, Z. B. Barakhoeva, S. V. Nikitin, I. A. Bendusov, Yu. A. Fetisova, M. A. Yudina, E. S. Tararashkina, D. T. Khetagurova, D. V. Blinov, M. A. Polzikov
Format: Article
Language:Russian
Published: IRBIS LLC 2021-03-01
Series:Акушерство, гинекология и репродукция
Subjects:
follitropin alpha
recombinant follicle-stimulating hormone
fsh
biosimilar
in vitro fertilization
ivf
assisted reproductive technologies
art
Online Access:https://www.gynecology.su/jour/article/view/920

Internet

https://www.gynecology.su/jour/article/view/920

Similar Items